SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-21-001089
Filing Date
2021-03-18
Accepted
2021-03-18 09:03:44
Documents
73
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2125654.htm 20-F 1942938
2 EXHIBIT 2.1 exhibit_2-1.htm EX-2.1 46613
3 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 10505
4 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 10661
5 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 6145
6 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5719
  Complete submission text file 0001178913-21-001089.txt   6298236

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT prfx-20201231.xml EX-101.INS 1138279
8 XBRL TAXONOMY EXTENSION SCHEMA prfx-20201231.xsd EX-101.SCH 46927
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prfx-20201231_cal.xml EX-101.CAL 56294
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prfx-20201231_def.xml EX-101.DEF 168929
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE prfx-20201231_lab.xml EX-101.LAB 325010
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prfx-20201231_pre.xml EX-101.PRE 264863
Mailing Address 4 BRURIA ST. TEL AVIV L3 6745442
Business Address 4 BRURIA ST. TEL AVIV L3 6745442 972-9-960-1901
PAINREFORM LTD. (Filer) CIK: 0001801834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39481 | Film No.: 21753222
SIC: 2834 Pharmaceutical Preparations